Background and Purpose-Optimal management of the extracranial occlusive component remains controversial in patients with acute ischemic stroke by tandem occlusion treated with mechanical thrombectomy. We investigated the association between extracranial internal carotid artery (ICA) patency at day 1 and the clinical outcome after mechanical thrombectomy. Methods-Consecutive patients with acute ischemic stroke with tandem occlusion were identified from a hospital-based prospective registry from 2011 to 2017. Baseline characteristics, angiographic outcomes, and day 1 ICA patency assessed by MR angiography were analyzed with regard to their associations with 3-month modified Rankin Scale scores. Favorable outcome was defined as a modified Rankin Scale score of 0 to 2 at 3 months. Results-Of 594 patients with acute ischemic stroke treated with mechanical thrombectomy during the study period, 83 met inclusion criteria. Successful recanalization (modified Thrombolysis in Cerebral Infarction, 2b/3) was achieved in 61.5%. Extracranial ICA was patent in 37 of 83 patients (44.6%) at day 1, more frequently in those with prior intravenous thrombolysis (P=0.035) or with cervical revascularization procedure (balloon angioplasty or stenting, P=0.034). Favorable 3-month functional outcome was more frequent in patients with patent extracranial ICA at day 1 (adjusted odds ratio, 4.72; 95% CI, 1.76-13.34; P=0.003) independent of intracranial recanalization success. Conclusions-Day 1 stable extracranial ICA patency is associated with better clinical outcome in patients with acute ischemic stroke with tandem occlusions. Randomized studies are needed.
R ecent randomized trial subgroup analyses
1,2 demonstrated encouraging results of mechanical thrombectomy (MT) in patients with acute ischemic stroke because of tandem occlusion (defined as a proximal intracranial occlusion with a concomitant occlusion or high-grade stenosis >90% of the extracranial internal carotid artery [ICA] ). However, controversies remain about the management of the extracranial ICA occlusion, and the optimal approach is yet to be determined. We investigated the association between extracranial ICA patency on day 1 follow-up MR angiography and the clinical outcomes after MT in tandem occlusion patients with ischemic stroke.
Methods
The local IRB approved the study (No. 10.677), and consent was obtained.
The data that support the findings of this study are available from the corresponding author on reasonable request.
Population
Consecutive patients with acute ischemic stroke LVO with tandem occlusion who underwent MT between January 2011 and January 2017 were included. Eligibility criteria for intravenous thrombolysis and MT were published previously. 3 Patients underwent brain magnetic resonance imaging with time-of-flight MR angiography as the first-line imaging (or CT/CT angiography, if contraindication). Tandem occlusions were confirmed on initial angiogram during endovascular procedure. Day 1 follow-up brain CT or MR angiography were routinely performed 24 to 36 hours after treatment. Favorable outcome defined as a 3-month mRS score of 0 to 2 or similar to the prestroke mRS score was chosen as primary outcome. Secondary outcomes included the overall distribution of 3-month mRS (shift analysis), the rate of symptomatic intracerebral hemorrhage, and mortality.
Day 1 Extracranial Internal

Imaging and Procedural Data Collection
All images were reviewed by neuroradiologists blinded to clinical data. Management of the extracranial ICA could involve balloon angioplasty or stenting, depending on operator's choice. Carotid revascularization took place after intracranial recanalization whenever possible, as a retrograde approach. Patency of the extracranial ICA on day 1 imaging was evaluated on contrast-enhanced MR angiography or CT angiography and defined as a normal antegrade blood flow in the target carotid artery (pseudo-occlusion or string sign was not considered as patent).
Concomitant carotid angioplasty or stenting at the time of thrombectomy and procedure-related adverse events were recorded. Antithrombotic regimen is indicated in Appendix in the online-only Data Supplement.
Statistical Analysis
Detailed statistical methods are available in Appendix in the onlineonly Data Supplement. Bivariate comparisons between the 2 study groups were made as appropriate with and without stratification for the presence/absence of successful recanalization. Association of patency of extracranial ICA with favorable outcome was further adjusted on baseline between-group differences (at P <0.10 in bivariate analyses) using a penalized-likelihood logistic regression mode.Statistical testing was done at the 2-tailed α-level of 0.05. Data were analyzed using the SAS software package, release 9.4 (SAS Institute, Cary, NC).
Results
Among the 594 anterior circulation patients with acute ischemic stroke treated by MT during the study period, 83 consecutive patients met inclusion criteria. Patients' characteristics for the overall study population and according to day 1 extracranial ICA patency are described in Table I in the online-only Data Supplement. Cervical carotid artery revascularization procedures were performed in 30 patients (36.1%), including 10 stenting and 20 balloon angioplasty.
On day 1 imaging (82 MR angiography, 1 CT angiography), the extracranial ICA was patent in 44.6% patients (n=37; 95% CI, 33.8%-55.3%). Extracranial ICA patency was associated with the use of a cervical carotid artery revascularization procedure and with use of intravenous thrombolysis before MT.
Outcomes and Patency of Extracranial ICA
The distribution of the 3-month mRS scores according to study groups is shown in Figure I in the online-only Data Supplement. As shown in the Table, a favorable outcome was more frequent in patients with day 1 patent extracranial ICA (64.9% vs 21.7%; odds ratio, 6.65; 95% CI, 2.51-17.58; P<0.0001), and similar associations were found after stratification by intracranial recanalization success (Figure) . After adjustment for cervical carotid artery revascularization procedure and use of intravenous thrombolysis before MT, the association between patent extracranial ICA and favorable outcome remained significant (adjusted odds ratio, 4.72; 95% CI, 1.76-13.34; P=0.003). Results of secondary outcomes are presented in the Table.
Discussion
We showed, in a large sample of patients with stroke with tandem occlusion treated with MT at a single academic comprehensive stroke center, that patency of extracranial ICA at day 1 may be associated with favorable functional outcome, found to be 3× higher in patients with stable extracranial ICA patency.
Our findings are in accordance with data from previous meta-analyses, which concur in suggesting the safety and efficacy of the restoration of a fully antegrade flow in the target carotid artery whenever achievable. 4, 5 However, stable extracranial ICA patency after initial treatment and its association with clinical outcome were not reported previously. As a consequence, available data do not allow us to determine whether there is a clear clinical benefit in treating the extracranial ICA 
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occlusion when a successful recanalization of the intracranial arteries has been obtained. Moreover, concomitant ICA stenting requires the administration of antiplatelet therapy to prevent in-stent thrombosis, but it might increase the risk of intracerebral hemorrhage in patients with stroke who may have received intravenous thrombolysis. A recent meta-analysis 4 reported an 8% (95% CI, 6%-11%) rate of symptomatic intracerebral hemorrhage after MT in tandem patients. We found a 12.1% rate of symptomatic intracerebral hemorrhage in our study, but it increased from 5% in patients treated with balloon angioplasty after MT (n=20) to 20% in the small subgroup of patients treated with concomitant carotid stenting (n=10). These data could highlight the potential increased intracranial bleeding risk related to the administration of antiplatelet therapy in patients treated with stent implantation.
Our results suggest that good outcome is related to stable patency of extracranial ICA, which was more frequently observed in patients treated with balloon angioplasty (55%) or stenting (70.0%) than in patients who underwent conservative management (35.9%). Balloon angioplasty without stent implantation does not require antiplatelet treatment, and it could be considered as a safe alternative to stent implantation, especially in the subgroup of patients supposed to be at higher risk of parenchymal hemorrhage (eg, large volume core 6 ). Our results highlight for the first time the potential benefit to restore antegrade blood flow of the extracranial ICA regardless of the success of intracranial recanalization. Our findings may be explained by several factors. First, early reocclusion of the extracranial ICA may be associated with intracranial reembolization from a thrombogenic atherosclerotic plaque or dissection, which may lead to new cerebral infarct. Second, early reocclusion of the extracranial ICA may be responsible for cerebral hypoperfusion and hemodynamic stroke because of poor or insufficient collateral supply via the Willis circle, leptomeningeal collaterals, or external carotid artery anastomosis.
The strengths of the present study are the rigorous prospective data collection (no missing data), a magnetic resonance imaging-based selection of patients, and a longitudinal follow-up at day 1.
The main limitation of the present study is related to the relatively small sample size, despite being one of the largest reported series of patients with tandem lesions treated by MT. We acknowledge that the association may be because of indication bias, by which targeted extracranial procedures may have been performed in patients inherently at higher odds of favorable outcome. Further, given the study inclusion period, a treatment bias cannot be excluded. Additionally, we may have lacked statistical power to detect meaningful difference between the 2 study groups. In a posterior power calculation, we calculated the smallest significant between-group difference (expressed as effect size using risk ratio) that our study sample size allowed us to detect with an 80% power. Assuming an incidence of outcome of 10% and 50% in the reference group (absence of patency of extracranial ICA), we could, respectively, detect an RR of 3.51 and 1.58. Finally, the current results are derived from a single-center patient population, limiting generalizability.
Conclusions
Overall, we provide novel evidence that a stable extracranial ICA patency 24 hours after MT for acute ischemic stroke LVO with tandem occlusion was associated with better 3-month clinical outcome, supporting a potential additional benefit of a targeted revascularization procedure of the extracranial ICA in addition to intracranial MT. These results call for a randomized study with a pragmatic design.
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